Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy LeMaitre Vascular stock

Learn how to easily invest in LeMaitre Vascular stock.

LeMaitre Vascular is a medical instruments & supplies business based in the US. LeMaitre Vascular shares (LMAT) are listed on the NASDAQ and all prices are listed in US Dollars. LeMaitre Vascular employs 450 staff and has a trailing 12-month revenue of around $160.2 million.

How to buy LeMaitre Vascular stock

  1. Open a stock trading account. Use our comparison table or choose from our Top Picks.
  2. Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
  3. Search for the stock by name or ticker symbol – LMAT. It's that simple.

Best for low fees

Finder Award

SoFi Invest

  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Promoted for easy user experience


  • Commission-free trading
  • Commission-free crypto
  • No minimum account balance



  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.

LeMaitre Vascular stock price (NASDAQ: LMAT)

Use our graph to track the performance of LMAT stocks over time.

LeMaitre Vascular shares at a glance

Information last updated 2023-01-26.
Latest market close$45.88
52-week range$38.01 - $56.09
50-day moving average $45.96
200-day moving average $47.10
Wall St. target price$61.00
PE ratio 49.0947
Dividend yield $0.485 (1.07%)
Earnings per share (TTM) $0.95

Buy LeMaitre Vascular stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
Stocks, Options, ETFs, Cryptocurrency
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Stocks, ETFs, Cryptocurrency, Alternatives
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
Winner of Finder’s Best Overall Stock Broker award.

Compare up to 4 providers

*Signup bonus information updated weekly.

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy LeMaitre Vascular stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

LeMaitre Vascular price performance over time

Historical closes compared with the close of $45.88 from 2023-01-27

1 week (2023-01-23) -3.23%
1 month (2022-12-30) -0.30%
3 months (2022-10-28) 9.39%
6 months (2022-07-29) -8.88%
1 year (2022-01-28) 11.88%
2 years (2021-01-29) -4.54%
3 years (2020-01-30) 28.59%
5 years (2018-01-30) 29.64%

Is LeMaitre Vascular stock undervalued or overvalued?

Valuing LeMaitre Vascular stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of LeMaitre Vascular's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

LeMaitre Vascular's P/E ratio

LeMaitre Vascular's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 49x. In other words, LeMaitre Vascular shares trade at around 49x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

LeMaitre Vascular's PEG ratio

LeMaitre Vascular's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 4.005. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into LeMaitre Vascular's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

LeMaitre Vascular's EBITDA

LeMaitre Vascular's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $41.3 million.

The EBITDA is a measure of a LeMaitre Vascular's overall financial performance and is widely used to measure a its profitability.

LeMaitre Vascular financials

Revenue TTM $160.2 million
Operating margin TTM 19.52%
Gross profit TTM $101.4 million
Return on assets TTM 6.61%
Return on equity TTM 8.3%
Profit margin 13.22%
Book value $11.87
Market capitalisation $1 billion

TTM: trailing 12 months

LeMaitre Vascular share dividends


Dividend payout ratio: 52.08% of net profits

Recently LeMaitre Vascular has paid out, on average, around 52.08% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.07% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), LeMaitre Vascular shareholders could enjoy a 1.07% return on their shares, in the form of dividend payments. In LeMaitre Vascular's case, that would currently equate to about $0.485 per share.

LeMaitre Vascular's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.

LeMaitre Vascular's most recent dividend payout was on 30 November 2022. The latest dividend was paid out to all shareholders who bought their shares by 15 November 2022 (the "ex-dividend date").

LeMaitre Vascular share price volatility

Over the last 12 months, LeMaitre Vascular's shares have ranged in value from as little as $38.0135 up to $56.0906. A popular way to gauge a stock's volatility is its "beta".

LMAT.US volatility(beta: 1)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while LeMaitre Vascular's is 0.999. This would suggest that LeMaitre Vascular's shares are less volatile than average (for this exchange).

LeMaitre Vascular overview

LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. The company also provides carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin. In addition, it offers valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, the company provides vascular and cardiac patches, which are used for closure of vessels after surgical intervention; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors.

Frequently asked questions

What percentage of LeMaitre Vascular is owned by insiders or institutions?
Currently 11.607% of LeMaitre Vascular shares are held by insiders and 89.173% by institutions.
How many people work for LeMaitre Vascular?
Latest data suggests 450 work at LeMaitre Vascular.
When does the fiscal year end for LeMaitre Vascular?
LeMaitre Vascular's fiscal year ends in December.
Where is LeMaitre Vascular based?
LeMaitre Vascular's address is: 63 Second Avenue, Burlington, MA, United States, 01803
What is LeMaitre Vascular's ISIN number?
LeMaitre Vascular's international securities identification number is: US5255582018
What is LeMaitre Vascular's CUSIP number?
LeMaitre Vascular's Committee on Uniform Securities Identification Procedures number is: 525558201

More guides on Finder

Ask an Expert provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site